Amino acid-based ionic liquids as antimicrobial surfactants for cleaning and disinfection

Overview

This research proposes the rational design and synthesis of amino acid-based ionic liquid (IL) surfactants as next-generation antimicrobial agents for cleaning and disinfection. Amino acid surfactants are well recognized for being mild to skin and non-sensitizing, making them attractive candidates for consumer product formulations. The project focuses on evaluating structural-antimicrobial activity relationships to identify a lead compound with broad-spectrum efficacy. By combining the established antimicrobial potential of IL surfactants with the biocompatibility and biodegradability of amino acid building blocks, this work aims to deliver an environmentally benign antimicrobial ingredient suitable for use in personal care, household, and industrial cleaning products.

Technical specifications

Core design features:

• Cationic surfactant architecture comprising a hydrophobic tail (C8–C18), optionally functionalized with a terminal double bond for polymerization, connected via a biodegradable linker to a polar head group
• Two biodegradable linker chemistries under investigation: carbamate (Series I) and ureido (Series II), both designed to be cleavable by hydrolytic enzymes
• Chiral head groups using L-, D-, or racemic amino alcohols and other chiral-center-bearing molecules to study the influence of optical configuration on antimicrobial efficiency
• Counter-ion variation with both inorganic and organic acid counter ions (Series III) to optimize antimicrobial performance
• Mechanistic analogy to established ILs containing cleavable carbonate linkages, supporting predicted biodegradability and low toxicity

Antimicrobial validation approach:

• Minimum inhibitory concentration (MIC) determination via broth microdilution against Gram-positive cocci and bacilli, Gram-negative rods, and fungal strains
• Structure-activity relationship analysis plotting mean MIC values across carbamate and ureido homologs to identify the influence of electronic, steric, and lipophilic properties

Technology readiness level

The technology is at an early-stage research and development phase (TRL 2–3). Several IL derivatives with varied hydrophobic tail lengths, linker chemistries, and chiral head groups have already been synthesized in the investigator's laboratory. Future work will focus on systematic antimicrobial screening, structure-activity analysis, and identification of a lead compound with broad-spectrum efficacy. The technology is not yet validated in formulated products or commercial applications and requires further optimization and efficacy testing before advancing toward prototype development and scale-up.